Erratum: Jayappa KD, Portell CA, Gordon VL, et al. Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Adv. 2017;1(14):933-946

DOI: https://doi.org/10.1182/bloodadvances.2017011148

2017-08-17

Abstract:[This corrects the article DOI: 10.1182/bloodadvances.2016004176.].

What problem does this paper attempt to address?

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Chao Hu,Mengxia Yu,Yanling Ren,Kongfei Li,Dominic M. Maggio,Chen Mei,Li Ye,Juying Wei,Jie Jin,Zhengping Zhuang,Hongyan Tong

DOI: https://doi.org/10.1038/s41598-017-14858-z

IF: 4.6

2017-01-01

Scientific Reports

Abstract:correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.
Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

DOI: https://doi.org/10.1182/blood-2016-06-725010

IF: 20.3

2016-08-18

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2015-04-639203.].
Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Erratum: Richardson PG, Hungria VTM, Yoon S-S, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood. 2016;127(6):713-721

DOI: https://doi.org/10.1182/blood-2016-05-717777

IF: 20.3

2016-06-30

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2015-09-665018.].
Erratum: Schwartz CL, Constine LS, Villaluna D, et al. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood. 2009;114(10):2051-2059

DOI: https://doi.org/10.1182/blood-2016-06-723056

IF: 20.3

2016-07-28

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2008-10-184143.].
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Frontiers Production Office

DOI: https://doi.org/10.3389/fphar.2022.1092147

IF: 5.6

2022-11-22

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.973448.].

pharmacology & pharmacy
Erratum: Palumbo A, Bringhen S, Mateos M-V, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125(13):2068-2074

DOI: https://doi.org/10.1182/blood-2016-07-727081

IF: 20.3

2016-08-18

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2014-12-615187.].
Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [ Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188]

Maxime Teisseyre,Sonia Boyer-Suavet,Marion Crémoni,Vesna Brglez,Vincent Esnault,Barbara Seitz-Polski

DOI: https://doi.org/10.1016/j.ekir.2024.05.020

2024-05-23

Abstract:[This corrects the article DOI: 10.1016/j.ekir.2021.01.022.].
Erratum: Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy: Erratum

DOI: https://doi.org/10.1097/JD9.0000000000000184

Abstract:[This corrects the article DOI: 10.1097/JD9.0000000000000170.].
Erratum: Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347

DOI: https://doi.org/10.1182/bloodadvances.2017015438

2018-01-09

Abstract:[This corrects the article DOI: 10.1182/bloodadvances.2017012732.].
Erratum: Zeiser R, Blazar BR. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Blood. 2016;127(25):3117-3126

DOI: https://doi.org/10.1182/blood-2016-07-730580

IF: 20.3

2016-09-08

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2016-02-699082.].
Erratum: Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia

DOI: https://doi.org/10.1097/BS9.0000000000000185

2024-03-07

Abstract:[This corrects the article DOI: 10.1097/BS9.0000000000000179.].
Erratum: Veenstra RG, Flynn R, Kreymborg K, et al. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood. 2015;125(21):3335-3346

DOI: https://doi.org/10.1182/blood-2016-04-711242

IF: 20.3

2016-06-16

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2014-09-603357.].
Erratum: Parry EM, Alder JK, Qi X, Chen JJ-L, Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011;117(21):5607-5611

DOI: https://doi.org/10.1182/blood-2016-02-700880

IF: 20.3

2016-04-07

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2010-11-322149.].
Erratum: Aldenhoven M, van den Broek BTA, Wynn RF, et al. Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation. Blood Adv. 2017;1(24):2236-2242

DOI: https://doi.org/10.1182/bloodadvances.2017014407

2017-12-07

Abstract:[This corrects the article DOI: 10.1182/bloodadvances.2017011387.].
Erratum: Wang L, Man N, Sun X-J, et al. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. Blood. 2015;126(5):640-650

DOI: https://doi.org/10.1182/blood-2016-03-703744

IF: 20.3

2016-04-14

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2015-03-635532.].
Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum

Zhongqing Zou,Tingting Guo,Jian Cui,Wenjiao Tang,Yan Li,Fangfang Wang,Tian Dong,Yunfan Yang,Yan Feng,Matthew Ho,Li Zhang,Ling Pan,Ting Niu

DOI: https://doi.org/10.7150/jca.79561

IF: 3.9

2022-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.53209.].

oncology
Erratum: Development of Auer bodies from giant inclusions associated with rough endoplasmic reticulum in acute promyelocytic leukemia

DOI: https://doi.org/10.1097/BS9.0000000000000163

2023-05-30

Abstract:[This corrects the article DOI: 10.1097/BS9.0000000000000145.].
Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

DOI: https://doi.org/10.1177/17588359241290373

2024-10-21

Abstract:[This corrects the article DOI: 10.1177/17588359241267148.].
Erratum: New insights into the role of macrophages in cancer immunotherapy

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1427337

IF: 7.3

2024-05-17

Frontiers in Immunology

Abstract:This article is an erratum on: New insights into the role of macrophages in cancer immunotherapy

immunology

Erratum: Jayappa KD, Portell CA, Gordon VL, et al. Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Adv. 2017;1(14):933-946

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Erratum: Richardson PG, Hungria VTM, Yoon S-S, et al. Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment. Blood. 2016;127(6):713-721

Erratum: Schwartz CL, Constine LS, Villaluna D, et al. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood. 2009;114(10):2051-2059

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Erratum: Palumbo A, Bringhen S, Mateos M-V, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125(13):2068-2074

Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [ Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188]

Erratum: Genetic Predisposition to Numerous Large Ulcerating Basal Cell Carcinomas and Response to Immune Therapy: Erratum

Erratum: Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347

Erratum: Zeiser R, Blazar BR. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Blood. 2016;127(25):3117-3126

Erratum: Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia

Erratum: Veenstra RG, Flynn R, Kreymborg K, et al. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood. 2015;125(21):3335-3346

Erratum: Parry EM, Alder JK, Qi X, Chen JJ-L, Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011;117(21):5607-5611

Erratum: Aldenhoven M, van den Broek BTA, Wynn RF, et al. Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation. Blood Adv. 2017;1(24):2236-2242

Erratum: Wang L, Man N, Sun X-J, et al. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. Blood. 2015;126(5):640-650

Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum

Erratum: Development of Auer bodies from giant inclusions associated with rough endoplasmic reticulum in acute promyelocytic leukemia

Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

Erratum: New insights into the role of macrophages in cancer immunotherapy